New hope for stubborn eye disease: arthritis drug shows promise

This study tests baricitinib, a drug used for arthritis, in 33 adults with a type of eye inflammation (uveitis) that hasn't improved with other treatments. The goal is to see if it can stop the inflammation completely after 6 months. Participants must stop their current medications before starting baricitinib, but may need long-term treatment to keep the disease under control.